Clinical Trial

Primary Tumor Radiotherapy Omitting CTV for Patients With Advanced NSCLC Responded to Immunotherapy and Chemotherapy

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 15, 2024 (before its estimated March 13, 2026 completion). Its status may not reflect the trial's current state.
Summary
The aim of this randomized study is to investigate pneumonitis, local tumor control, and survival outcomes of primary tumor radiotherapy omitting CTV for patients with advanced NSCLC responded to immunotherapy and chemotherapy
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2023-09-07.
Status change: Not Yet Recruiting → Recruiting 2024-03-13
Trial Details
NCT Number NCT06037733
Lead Sponsor Hubei Cancer Hospital
Conditions Advanced Non-Small Cell Squamous Lung Cancer, Radiotherapy, Immunotherapy
Enrollment 134 participants
Start Date 2024-03-13
Primary Completion 2026-03-13 (estimated)
Study Completion 2027-10-08 (estimated)
Updated on ClinicalTrials.gov 2024-03-15